Janus Henderson Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Hold |
25,642
| – | – | ﹤0.01% | 1930 |
|
|
2025
Q1 | $511K | Hold |
25,642
| – | – | ﹤0.01% | 1949 |
|
|
2024
Q4 | $647K | Hold |
25,642
| – | – | ﹤0.01% | 1907 |
|
|
2024
Q3 | $871K | Hold |
25,642
| – | – | ﹤0.01% | 1743 |
|
|
2024
Q2 | $950K | Sell |
25,642
-280
| -1% | -$10.4K | ﹤0.01% | 1648 |
|
|
2024
Q1 | $1.09M | Buy |
25,922
+39
| +0.2% | +$1.63K | ﹤0.01% | 1600 |
|
|
2023
Q4 | $1.03M | Buy |
25,883
+8,863
| +52% | +$352K | ﹤0.01% | 1601 |
|
|
2023
Q3 | $468K | Hold |
17,020
| – | – | ﹤0.01% | 1952 |
|
|
2023
Q2 | $577K | Sell |
17,020
-25
| -0.1% | -$848 | ﹤0.01% | 1899 |
|
|
2023
Q1 | $614K | Buy |
17,045
+8,961
| +111% | +$323K | ﹤0.01% | 1901 |
|
|
2022
Q4 | $360K | Buy |
8,084
+1
| +0% | +$45 | ﹤0.01% | 1885 |
|
|
2022
Q3 | $227K | Buy |
8,083
+21
| +0.3% | +$590 | ﹤0.01% | 2347 |
|
|
2022
Q2 | $217K | Sell |
8,062
-19
| -0.2% | -$511 | ﹤0.01% | 2259 |
|
|
2022
Q1 | $275K | Buy |
8,081
+2
| +0% | +$68 | ﹤0.01% | 2276 |
|
|
2021
Q4 | $312K | Buy |
8,079
+4,072
| +102% | +$157K | ﹤0.01% | 2179 |
|
|
2021
Q3 | $216K | Buy |
+4,007
| New | +$216K | ﹤0.01% | 2041 |
|